Gail Bishop

Gail Bishop is a Professor of Microbiology and Immunology and Internal Medicine at the University of Iowa College of Medicine. She serves as Associate Director for Basic Science Research at the Holden Comprehensive Cancer Center and holds the Holden Chair of Cancer Biology. Her lab investigates molecular mechanisms of lymphocyte activation, tolerance, and immune cell signaling.

• Biochemistry
• Immunology
• Cell Signaling
• Cancer Biology

Dr. Bishop's research focuses on:

• TRAF3 regulation of B and T cell survival/activation
• CD40 signaling in antiviral immunity
• Immune receptor cross-talk between innate and adaptive systems
• Mechanisms of TRAF3 tumor suppression
• Role of TRAF3 loss in autoimmunity and aging
• Signal transduction pathways in lymphocytes

Her recent publications highlight innovations in:

• T follicular helper cell specification mechanisms
• TLR signaling regulation in B cells
• TRAF3-JAK-TCPTP interactions in T cells
• CD40-mediated innate resistance to RNA viruses

Scientific accolades include:

• AAI Distinguished Fellow (2019)
• AAAS Fellow (2020)
• Hubbard-Walder Teaching Excellence Award (2022)
• Society for Leukocyte Biology Honorary Life Membership (2022)

As Editor-in-Chief of The Journal of Immunology (2024-), she continues mentoring trainees through active lab participation and educational leadership. Key collaborations span virology, cancer biology, and immunometabolism research domains.